CHICAGO, May 15, 2025--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company focused ... trial was accepted for poster presentation at the ...

--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced today that the company will be presenting 16 posters and exhibiting at booth 223 at the ...

Poster presentation to highlight the ongoing global Phase 3 ASP-1929-381 study at ASCO 2025Global patient enrollment continues, with Taiwan now actively enrolling following the U.S., and Japan ...

Oct. 08, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (Nasdaq ... A copy of the posters will be added to the Scientific Publications page of the Company’s website at https://nkgenbiotech.com ...

MAIA Biotechnology ... company developing targeted immunotherapies for cancer, today announced that an abstract detailing a potential predictive biomarker for THIO treatment was selected for ...

PanGIA Biotech, a company advancing urine-based ... biopsy (Abstract #3080), has been accepted for presentation in the poster session titled Developmental Therapeutics—Molecularly Targeted ...

Taiwan opened a biotech exhibition Thursday to showcase a broad array of state-of-the-art products it hopes will give it a leg up in the highly competitive biotech field. More than 100 companies ...

The festival will use performance to create a futuristic world based on a fictitious company called Unlimited Enhancement ... and lighting to really elevate what would otherwise be an exhibition to a ...

CHICAGO--(BUSINESS WIRE)-- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing ...